These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 8862962)

  • 21. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
    Peterson WL
    Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():21-5. PubMed ID: 9146787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic options after failed Helicobacter pylori eradication therapy.
    van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN
    Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
    Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
    Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea.
    Choe JW; Jung SW; Kim SY; Hyun JJ; Jung YK; Koo JS; Yim HJ; Lee SW
    Helicobacter; 2018 Apr; 23(2):e12466. PubMed ID: 29369454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.
    Huang WH; Ho AS; Shyu RY; Lee SC; Lee MM; Hsu CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):448-55. PubMed ID: 9745160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of Helicobacter pylori eradication: is poor compliance the main cause?
    Wermeille J; Cunningham M; Dederding JP; Girard L; Baumann R; Zelger G; Buri P; Metry JM; Sitavanc R; Gallaz L; Merki H; Godin N
    Gastroenterol Clin Biol; 2002 Mar; 26(3):216-9. PubMed ID: 11981460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
    Lo WC; Lin HJ; Wang K; Perng CL; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):171-6. PubMed ID: 9198292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
    Ghadir MR; Shafaghi A; Iranikhah A; Pakdin A; Joukar F; Mansour-Ghanaei F
    Turk J Gastroenterol; 2011 Feb; 22(1):1-5. PubMed ID: 21480103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.